These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

379 related articles for article (PubMed ID: 22527184)

  • 1. Long-term follow up of patients who were positive for peritoneal lavage cytology: final report from the CCOG0301 study.
    Kodera Y; Ito S; Mochizuki Y; Ohashi N; Tanaka C; Kobayashi D; Kojima H; Matsui T; Kondo K; Fujiwara M
    Gastric Cancer; 2012 Jul; 15(3):335-7. PubMed ID: 22527184
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A phase II study of radical surgery followed by postoperative chemotherapy with S-1 for gastric carcinoma with free cancer cells in the peritoneal cavity (CCOG0301 study).
    Kodera Y; Ito S; Mochizuki Y; Kondo K; Koshikawa K; Suzuki N; Kojima H; Kojima T; Matsui T; Takase T; Tsuboi K; Fujiwara M; Nakao A;
    Eur J Surg Oncol; 2009 Nov; 35(11):1158-63. PubMed ID: 19328643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The survival and prognosticators of peritoneal cytology-positive gastric cancer patients who received upfront gastrectomy and subsequent S-1 chemotherapy.
    Kano K; Aoyama T; Maezawa Y; Nakajima T; Ikeda K; Yamada T; Sato T; Oshima T; Rino Y; Masuda M; Ogata T; Cho H; Yoshikawa T
    Int J Clin Oncol; 2017 Oct; 22(5):887-896. PubMed ID: 28456896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of Postoperative Chemotherapy After Resection that Leaves No Macroscopically Visible Disease of Gastric Cancer with Positive Peritoneal Lavage Cytology (CY1) or Localized Peritoneum Metastasis (P1a): A Multicenter Retrospective Study.
    Yamaguchi T; Takashima A; Nagashima K; Makuuchi R; Aizawa M; Ohashi M; Tashiro K; Yamada T; Kinoshita T; Hata H; Kawachi Y; Kawabata R; Tsuji T; Hihara J; Sakamoto T; Fukagawa T; Katai H; Higuchi K; Boku N
    Ann Surg Oncol; 2020 Jan; 27(1):284-292. PubMed ID: 31535301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [S-1 monotherapy achieved twenty-month survival for peritoneal lavage cytology-positive gastric cancer patient undergoing noncurative resection].
    Shimoyama S; Kiyokawa T; Nishida M; Seto Y
    Gan To Kagaku Ryoho; 2012 Sep; 39(9):1411-4. PubMed ID: 22996780
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gastrectomy as a secondary surgery for stage IV gastric cancer patients who underwent S-1-based chemotherapy: a multi-institute retrospective study.
    Kanda T; Yajima K; Kosugi S; Ishikawa T; Ajioka Y; Hatakeyama K
    Gastric Cancer; 2012 Jul; 15(3):235-44. PubMed ID: 22033890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adjuvant chemotherapy with S-1 followed by docetaxel for gastric cancer and CY1P0 peritoneal metastasis after relatively curative surgery.
    Kanazawa Y; Kato S; Fujita I; Onodera H; Uchida E
    J Nippon Med Sch; 2013; 80(5):378-83. PubMed ID: 24189356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced preoperative serum albumin and absence of peritoneal dissemination may be predictive factors for long-term survival with advanced gastric cancer with positive cytology test.
    Yamashita K; Ushiku H; Katada N; Hosoda K; Moriya H; Mieno H; Kikuchi S; Hoshi K; Watanabe M
    Eur J Surg Oncol; 2015 Oct; 41(10):1324-32. PubMed ID: 26251341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment strategy for patients with CY1 gastric cancer using subgroup analyses].
    Nagata H; Komatsu S; Ichikawa D; Kubota T; Okamoto K; Shiozaki A; Fujiwara H; Konishi H; Morimura R; Murayama Y; Kuriu Y; Ikoma H; Nakanishi M; Sakakura C; Otsuji E
    Gan To Kagaku Ryoho; 2014 Nov; 41(12):2235-8. PubMed ID: 25731481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A feasibility study of postoperative chemotherapy with S-1 and cisplatin (CDDP) for gastric carcinoma (CCOG0703).
    Kodera Y; Ishiyama A; Yoshikawa T; Kinoshita T; Ito S; Yokoyama H; Mochizuki Y; Ito H; Tsuburaya A; Sakamoto J; Nakao A;
    Gastric Cancer; 2010 Aug; 13(3):197-203. PubMed ID: 20820990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Favorable long-term outcomes of one-year adjuvant S-1 monotherapy for pathological stage II or III gastric cancer treated at a high-volume center.
    Kano Y; Ohashi M; Hiki N; Takahari D; Chin K; Yamaguchi K; Tsuda Y; Shoji Y; Yasufuku I; Eto K; Ida S; Kumagai K; Nunobe S; Sano T
    Gastric Cancer; 2018 Nov; 21(6):1024-1030. PubMed ID: 29700635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Two cases of long-term survival with CY1, stage IV gastric cancer due to surgery and postoperative chemotherapy].
    Tanida T; Aoki T; Igarashi Y; Tsukao Y; Komori T; Matsumoto T; Takachi K; Nishioka K; Uemura Y; Kobayashi K
    Gan To Kagaku Ryoho; 2008 Nov; 35(12):2063-5. PubMed ID: 19106524
    [TBL] [Abstract][Full Text] [Related]  

  • 13. D2-lymphadenectomy improves the survival of patients with peritoneal cytology-positive gastric cancer.
    Inada T; Ogata Y; Kubota T; Ishihara M; Tomikawa M; Ando J; Ozawa I; Hishinuma S; Shimizu H; Kotake K
    Anticancer Res; 2002; 22(1A):291-4. PubMed ID: 12017305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Peritoneal lavage cytology under local anesthesia for detection of peritoneal recurrence after surgery].
    Okada K; Fujiwara Y; Takahashi T; Kurokawa Y; Yamasaki M; Miyata H; Nakajima K; Takiguchi S; Mori M; Doki Y
    Gan To Kagaku Ryoho; 2011 Nov; 38(12):2363-5. PubMed ID: 22202383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical significance of cytological status of peritoneal lavage fluid during intraperitoneal chemotherapy for gastric cancer with overt peritoneal dissemination.
    Emoto S; Kitayama J; Ishigami H; Yamaguchi H; Watanabe T
    Ann Surg Oncol; 2015 Mar; 22(3):780-6. PubMed ID: 25216603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surgery after intraperitoneal and systemic chemotherapy for gastric cancer with peritoneal metastasis or positive peritoneal cytology findings.
    Ishigami H; Yamaguchi H; Yamashita H; Asakage M; Kitayama J
    Gastric Cancer; 2017 Mar; 20(Suppl 1):128-134. PubMed ID: 28028665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neoadjuvant chemotherapy with S-1 and surgical resection for a mucinous gastric cancer with peritoneal dissemination.
    Hamada M; Tsuji A; Iwata J; Nishioka Y; Ozaki K; Shima Y; Horimi T
    Gastric Cancer; 2005; 8(1):50-4. PubMed ID: 15747176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic effects of oral anti-cancer drugs as adjuvant chemotherapy for 2 years after gastric cancer surgery.
    Okuyama T; Korenaga D; Edagawa A; Itoh S; Oki E; Kawanaka H; Ikeda Y; Kakeji Y; Tateishi M; Tsujitani S; Takenaka K; Maehara Y
    Surg Today; 2012 Aug; 42(8):734-40. PubMed ID: 22278622
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Postoperative weight loss leads to poor survival through poor S-1 efficacy in patients with stage II/III gastric cancer.
    Aoyama T; Sato T; Maezawa Y; Kano K; Hayashi T; Yamada T; Yukawa N; Oshima T; Rino Y; Masuda M; Ogata T; Cho H; Yoshikawa T
    Int J Clin Oncol; 2017 Jun; 22(3):476-483. PubMed ID: 28176023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral fluoropyrimidine anticancer drug TS-1 for gastric cancer patients with peritoneal dissemination.
    Osugi H; Takada N; Takemura M; Kaseno S; Lee S; Ueno M; Tanaka Y; Fukuhara K; Fujiwara Y; Kinoshita H
    Oncol Rep; 2002; 9(4):811-5. PubMed ID: 12066214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.